Missouri Valley Cancer Consortium CCOP
密苏里河谷癌症联盟 CCOP
基本信息
- 批准号:6478025
- 负责人:
- 金额:$ 98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-09-30 至 2007-05-31
- 项目状态:已结题
- 来源:
- 关键词:antineoplastic antibiotics antineoplastics behavioral /social science research tag biliary tract neoplasm blood /lymphatic neoplasm bone neoplasms brain neoplasms breast neoplasms cancer complication cancer information system cancer prevention cancer registry /resource cancer rehabilitation /care ceramides chemoprevention clinical research colony stimulating factor community health services cooperative study data management esophagus neoplasm estrogens female reproductive system neoplasm gastrointestinal neoplasms head /neck neoplasm health services research tag hormone therapy human subject human therapy evaluation inhalation drug administration interferons interleukin 2 lung neoplasms medical outreach /case finding medical rehabilitation related tag melanoma neoplasm /cancer chemotherapy neoplasm /cancer education neoplasm /cancer genetics neoplasm /cancer immunotherapy neoplasm /cancer palliative treatment neoplasm /cancer radiation therapy neoplasm /cancer surgery neoplasm /cancer therapy pancreas neoplasms patient oriented research prostate neoplasms selenium tocopherols topical drug application
项目摘要
DESCRIPTION (provided by applicant): The Missouri Valley Cancer Consortium
(MVCC) is a community-based research effort with the specific aim of providing
quality cancer care and research opportunities to patients in their respective
communities. This is accomplished primarily through a networking of
physicians, hospitals, and community cancer clinics across Nebraska and Iowa
who recognize the unique needs of people with cancer, and who are committed to
providing cancer care that has an emphasis on research whereby patients may
benefit from cutting-edge technology in the areas of cancer treatment, cancer
control, and cancer prevention. The MVCC serves a catchment area of primarily
Nebraska and Iowa, and through affiliation with nationally recognized research
groups, clinical trials are offered for a wide variety of cancers. A unique
ability to provide clinical trials for cancer prevention and cancer control
enhances the quality of this vital research program. The MVCC has direct
affiliation with the North Central Cancer Treatment Group, Eastern Cooperative
Oncology Group, Radiation Therapy Oncology Group, National Surgical Adjuvant
Breast and Bowel Project, Gynecologic Oncology Group, and Southwest Oncology
Group, is a member of the CTSU, or Clinical Trials Support Unit of the NIH,
receives funding to support the program through an NIH grant as a Community
Clinical Oncology Program (CCOP), and serves a data base of well over 1800
patients who have enrolled in clinical research studies over the years through
their own community medical programs affiliated with MVCC. The MVCC has a
proven track record of producing quality research work from a deeply committed
team of healthcare professionals. Efforts are now being focused on community
awareness of the importance of clinical research participation through
pathways of public education about cancer, along with cancer screening and
cancer prevention programs. Strategies to include minority populations in
these important programs are being utilized as well. The long-term objective
of this vital research program is to provide cancer patients access to
clinical trials in their community, to promote quality cancer care and
education, and to produce research data that will ultimately benefit all
cancer patients.
描述(由申请人提供):密苏里谷癌症协会
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES A MAILLIARD其他文献
JAMES A MAILLIARD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES A MAILLIARD', 18)}}的其他基金
相似海外基金
The analysis of proteinuria caused by antineoplastics and the preventative effects with antihypertensive medications using the Japanese medical database
利用日本医学数据库分析抗肿瘤药物引起的蛋白尿及抗高血压药物的预防效果
- 批准号:
21K17258 - 财政年份:2021
- 资助金额:
$ 98万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Expediting Drug Development by Profiling Novel Antineoplastics by Mass Spectrometry-based Biomarker Profiling
通过基于质谱的生物标志物分析来分析新型抗肿瘤药物,加速药物开发
- 批准号:
499958-2016 - 财政年份:2016
- 资助金额:
$ 98万 - 项目类别:
Engage Grants Program
Novel Nanoparticle Delivery System for Antineoplastics
新型抗肿瘤纳米颗粒输送系统
- 批准号:
6483914 - 财政年份:2002
- 资助金额:
$ 98万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
6124630 - 财政年份:1998
- 资助金额:
$ 98万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
6329037 - 财政年份:1998
- 资助金额:
$ 98万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
2747737 - 财政年份:1998
- 资助金额:
$ 98万 - 项目类别:
POLYMORPHIC METABOLISM OF ANTINEOPLASTICS IN CHILDREN
儿童抗肿瘤药物的多态性代谢
- 批准号:
3459680 - 财政年份:1990
- 资助金额:
$ 98万 - 项目类别:
POLYMORPHIC METABOLISM OF ANTINEOPLASTICS IN CHILDREN
儿童抗肿瘤药物的多态性代谢
- 批准号:
3459678 - 财政年份:1990
- 资助金额:
$ 98万 - 项目类别:














{{item.name}}会员




